It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The process of bone resorption is regulated at multiple levels. Current bone-active therapies target bone resorption, whereas targets such as the formation of osteoclasts (OC) and their motility, fusion and lifespan have been largely unexplored. We and others have shown that RANKL and Activin A (ActA) are potent stimulators of murine bone marrow osteoclastogenesis. However, ActA treatment does not induce osteoclastogenesis in purified populations of murine bone marrow macrophages (BMM), but inhibits RANKL-induced OC development. We hypothesized that these factors differentially regulate the migration of both OC precursors and mature OC. We determined the effects of ActA and RANKL on BMM motility and bone resorption using time-lapse video microscopy. BMMs were plated onto culture dishes with 25 ng/ml mCSF alone for 24hr, prior to the addition of 100 ng/mL RANKL or 50 ng/mL ActA, alone or together, for up to 4d. Other BMMs were cultured on bone slices for 5d in the presence of mCSF+RANKL to stimulate OC differentiation prior to treatment with RANKL or ActA, alone or together for an additional 1-2d. The 4hr movement of ten OC precursors were tracked and analyzed with NIH ImageJ. Parameters calculated for each cell included cumulative track length, migration rate, maximum instantaneous velocity, range of velocity, and percent total displacement. BMMs migrated at a constant velocity and distance from d1-4. RANKL significantly increased parameters on d2 and d3, an effect that was lost by d4. In contrast, ActA treatment decreased all parameters on d1-4. Surprisingly, when added with RANKL, ActA treatment completely blocked all RANKL stimulated OC precursor motility on plastic, as well as mature RANKL-stimulated OC motility on bone slices. ActA treatment of mature OC (d5) also suppressed RANKL-stimulated bone resorption, measured by pit formation. The suppression was associated with a decrease in OC lifespan, since ActA increased activated Caspase 3, and caused a decrease in actin ring formation in mature OC on bone slices. Collectively these data indicate a dual modulatory function of ActA on OCs. ActA indirectly stimulates murine whole bone marrow osteoclastogenesis, but it also directly inhibits RANKL-induced murine OC differentiation, motility, and resorption and enhances OC apoptosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer